Work Group 1 Telecommunication develops and maintains standards and guidelines to accommodate the collection, transmission, and processing of information that may be exchanged electronically or in written formats. The information exchanged may be used for, but is not strictly limited to, such purposes as administering and certifying eligibility, establishing prior authorization for products and services, pharmacy claim billing, payment determination, denial of compensation with explanations, drug use review and the exchange of adjudicated data between business associates.
Work Group 2 Product Identification deals with issues relating to the identification of drugs and health related products within NCPDP’s stated mission. Identification consists of how the product is billed (billing units, quantity designations), product identification systems, and any type of descriptive data which serves to uniquely identify a product with the intent to establish standards for product identification such that there is no ambiguity in distinguishing one product from another.
Work Group 7 Manufacturer and Associated Trading Partner Transaction Standards develops, monitors, and maintains standards for the electronic exchange of data amongst manufacturers and trading partners to facilitate business processes. Additionally, the work group promotes implementation and education of the standards.
Work Group 9 Government Programs, in conjunction with Work Group 1 Telecommunication and other Work Groups, as necessary, guides and advises federal and state pharmacy programs and their agents on NCPDP standards. WG9 also supports data processing initiatives, and provides design alternatives for standards, which support government requirements.
Work Group 10 Professional Pharmacy Services supports the pharmacist’s individual and collaborative planning, delivery, documentation and quality assessment of patient care services through the development and distribution of standards, standards-based templates, and implementation guides. These documents/tools in conjunction with the publication of best practices recommendations encourage patient engagement, foster patient safety and support consistent delivery of patient care services to optimize outcomes.
WG10 strives to support pharmacists in utilizing their unique training and expertise to provide patient care services related to the appropriate use of medications. Patient care services are provided in many different practice settings and include activities such as medication therapy management, clinical reconciliation (medication, allergies and problems), patient immunization management, disease state monitoring, adverse drug event reporting and therapy adherence program management. Pharmacists contribute to improving patients’ health by providing patient care services as authorized by license and allowed under their scope of practice and collaborative practice agreements.
WG7 Manufacturer and Associated Trading Partner Transaction Standards Goals
- Promote NCPDP membership attendance, participation in task group calls and Work Group 7 participation by industry stakeholders via multiple methods, including but not limited to, manufacturer and associated trading partner surveys and other outreach.
- Maintain WG7 standards and associated reference guide to include changes necessary to meet evolving business and regulatory needs and, if appropriate, incorporate new technologies and standards.
- Manufacturer Rebate Utilization, Plan, Formulary, Market Basket and Reconciliation Flat File Standard
- Medical Rebate Data Submission Standard
- Provide examples and further explanation of the recent changes to incorporate the Formulary and Benefit Standard into the Manufacturer Rebate Standard. Use results to update the Manufacturer Rebate Reference Guide and build communication on how the standard could be used.
- Promote all standards developed by WG7 including increasing awareness, acceptance and use of the Medical Rebate Data Submission Standard.
- In conjunction with WG18 Specialty Pharmacy, identify impacted parties and develop requirements and specifications for a new mechanism for trading partners to exchange specialty pharmaceutical information.
- Work and align with other work groups to identify the impact of other standard changes on the WG7 Standards.
- Monitor WG7 task groups to ensure they are tracking scope, goals, and deliverables. Disband task groups that have completed their work.
- Support the MC Maintenance and Control Education-Legislation and Regulation Task Group when new legislation is being introduced regarding issues relevant to the work group.
- Review Data Element Request Forms (DERFs) and adjudicate ballots pertaining to standards for which this work group is responsible.
- Analyze, develop and execute Webinar opportunities for WG7 in coordination with Educational Programs Advisors Group.
For a list of acronyms, please see the Acronym Dictionary
WG7 Manufacturer and Associated Trading Partner Transaction Standards Scope
- Work Group 7 Manufacturer and Associated Trading Partner Transaction Standards develops, monitors, and maintains standards for the electronic exchange of data amongst manufacturers and trading partners to facilitate business processes. Additionally, the work group promotes implementation and education of the standards.